Development of a protein-coated microcrystal (PCMC) delivery system for full-length recombinant Factor H for use in the treatment of AHUS, dense deposit disease and AMD

Barlow, Paul (Principal Investigator)

Status	Finished
Effective start/end date	1/08/09 → 30/11/10

Funding

UK central government bodies/local authorities, health and hospital authorities: £93,696.00